These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15211441)
1. The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Svensson M; Christensen JH; Sølling J; Schmidt EB Am J Kidney Dis; 2004 Jul; 44(1):77-83. PubMed ID: 15211441 [TBL] [Abstract][Full Text] [Related]
2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Svensson M; Schmidt EB; Jørgensen KA; Christensen JH Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564 [TBL] [Abstract][Full Text] [Related]
3. The effect of n-3 polyunsaturated fatty acids on plasma lipids and lipoproteins in patients with chronic renal failure--a meta-analysis of randomized controlled trials. Pei J; Zhao Y; Huang L; Zhang X; Wu Y J Ren Nutr; 2012 Nov; 22(6):525-32. PubMed ID: 22698988 [TBL] [Abstract][Full Text] [Related]
4. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat. Morgado N; Rigotti A; Valenzuela A Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687 [TBL] [Abstract][Full Text] [Related]
5. Normal subjects consuming physiological levels of 18:3(n-3) and 20:5(n-3) from flaxseed or fish oils have characteristic differences in plasma lipid and lipoprotein fatty acid levels. Layne KS; Goh YK; Jumpsen JA; Ryan EA; Chow P; Clandinin MT J Nutr; 1996 Sep; 126(9):2130-40. PubMed ID: 8814201 [TBL] [Abstract][Full Text] [Related]
6. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study. Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722 [TBL] [Abstract][Full Text] [Related]
7. Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects. Foulon T; Richard MJ; Payen N; Bourrain JL; Beani JC; Laporte F; Hadjian A Scand J Clin Lab Invest; 1999 Jul; 59(4):239-48. PubMed ID: 10463462 [TBL] [Abstract][Full Text] [Related]
8. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Guebre-Egziabher F; Debard C; Drai J; Denis L; Pesenti S; Bienvenu J; Vidal H; Laville M; Fouque D Nutrition; 2013 May; 29(5):730-6. PubMed ID: 23375525 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of N-3 PUFAS on plasma lipoprotein levels and fatty acid composition of total serum and erythrocyte lipids in hypertriglyceridemic patients. Putadechakum S; Tanphaichitr V; Leelahagul P; Pakpeankitvatana V; Surapisitchart T; Komindr S J Med Assoc Thai; 2005 Feb; 88(2):181-6. PubMed ID: 15962668 [TBL] [Abstract][Full Text] [Related]
10. A Randomized Trial of ω-3 Fatty Acid Supplementation and Circulating Lipoprotein Subclasses in Healthy Older Adults. Moosavi D; Vuckovic I; Kunz HE; Lanza IR J Nutr; 2022 Jul; 152(7):1675-1689. PubMed ID: 35389487 [TBL] [Abstract][Full Text] [Related]
11. The effect of dietary fat level and quality on plasma lipoprotein lipids and plasma fatty acids in normocholesterolemic subjects. Sanders K; Johnson L; O'Dea K; Sinclair AJ Lipids; 1994 Feb; 29(2):129-38. PubMed ID: 8152346 [TBL] [Abstract][Full Text] [Related]
12. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study. Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375 [TBL] [Abstract][Full Text] [Related]
13. The acute effects of a single very high dose of n-3 fatty acids on plasma lipids and lipoproteins in healthy subjects. Svaneborg N; Møller JM; Schmidt EB; Varming K; Lervang HH; Dyerberg J Lipids; 1994 Feb; 29(2):145-7. PubMed ID: 8152348 [TBL] [Abstract][Full Text] [Related]
14. Fish-oil supplementation alters numbers of circulating endothelial progenitor cells and microparticles independently of eNOS genotype. Wu SY; Mayneris-Perxachs J; Lovegrove JA; Todd S; Yaqoob P Am J Clin Nutr; 2014 Nov; 100(5):1232-43. PubMed ID: 25332321 [TBL] [Abstract][Full Text] [Related]
16. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. Madsen T; Schmidt EB; Christensen JH J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424 [TBL] [Abstract][Full Text] [Related]
17. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Simons LA; Hickie JB; Balasubramaniam S Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229 [TBL] [Abstract][Full Text] [Related]
18. N-3 fatty acids from fish oil. Effects on plasma lipoproteins and hypertriglyceridemic patients. Connor WE; DeFrancesco CA; Connor SL Ann N Y Acad Sci; 1993 Jun; 683():16-34. PubMed ID: 8352438 [TBL] [Abstract][Full Text] [Related]
19. Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation. Schmidt S; Willers J; Stahl F; Mutz KO; Scheper T; Hahn A; Schuchardt JP Lipids Health Dis; 2012 Dec; 11():172. PubMed ID: 23241455 [TBL] [Abstract][Full Text] [Related]
20. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome. Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]